What we do
Atley develops technology for the scalable production of At-211 labeled radiopharmaceuticals. This technology is already enabling the development of new, efficient, and less toxic treatments for disseminated cancer.
Our technology offering spanns the At-211 radiopharmaceutical value chain and is centered around our flagship product: the Atley C100. This product is used to manufacture At-211-based radiopharmaceuticals in a scalable and reproducible manner, and is a pre-requisite for larger clinical trials and commercial roll out of such drug products.
Our product development requires a skilled and cross-functional team, blending mechanical engineering, material sciences, chemistry, software, electrical and electronic engineering, and beyond.
-
Consumables Project Manager – Atley SolutionsHardware & Software · Göteborg, Kristinehamn · Hybrid